Sage Therapeutics, Inc. - COM (SAGE)

Q3 2019 13F Holders as of 9/30/2019

Type / Class
Equity / COM
Number of holders
275
Total Shares
58.2M
Shares change
+268K
Total reported value, excl. options
$8.17B
Value change
+$23.5M
Put/Call ratio
1.26
Number of buys
137
Number of sells
-123
Price
$140.29
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.